Elevate NAD+
How we scored this product Show the full breakdown
Bevisning gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Säkerhet caps applied after weighting.
This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.
Question 1
Does the molecule work?
Does the molecule work?
Question 2
Is this bottle good?
Is this bottle good?
The specific product: dose, price, transparency, and what buyers report.
Question 3
What's the catch?
What's the catch?
Säkerhet flags, transparency gaps, dosing concerns, and recurring buyer complaints.
Quick verdict
The numbers
Data verification
Per-ingredient breakdown
All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Bevisning grades are reviewed when new human RCTs are published. Read how we verify.
What's inside
Consumer signals
Consumer signals gathered from 1 platform.
Medium confidenceThese are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.
What others say (unverified)
No external reviews aggregated yet for this product.
Research behind this product
The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.
Redaktionellt notes
Contains a 300 mg NAD Support Blend (NMN, nicotinamide riboside tartrate, liposomal quercetin, wasabi root extract) and a 150 mg Adaptogenic Longevity Blend (NooGandha ashwagandha, NordicCherry tart cherry, holy basil, ErgoActive ergothioneine). Individual ingredient amounts within each blend are not disclosed. Manufactured in a GMP-certified facility in the US.
Why this scored this way
This Gundry MD Elevate NAD+ scores 4.9, making it among the lowest-scoring produkter we track. It delivers 300mg of NMN (60% of the 500mg trial dose) with grade B evidence (promising human data, not yet comprehensive). At $8.33/day it's among the more expensive options in NAD+ booster.
What drives the score up
- Overall score of 4.9 with no single dominant strength.
What drags it down
- Dose-evidence score of 5.7 is below average for the site.
- Quercetin (150mg is 30% of the 500mg trial dose) is significantly under-dosed.
- No public analysintyg available for independent verification.
- Quality transparency of 3.0 is below the site average.
- Limited consumer feedback (community score: 6.0).
Why you'd choose it
- You want NMN from a Gundry MD product.
- You want a tested by independent lab product.
Why you might skip it
- You want a product with a publicly available CoA.
- You need a full trial dose of quercetin (this product under-doses it).
- You want a cheaper option (this is $8.33/day).
Where this sits
Spot an error?
If you are the manufacturer or brand owner of Elevate NAD+ and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.
We review every request, verify it against primär sources, and publish any change with a dated note in the version history above. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.
Request a correction →Similar produkter
All NAD+ booster →The next highest-scoring produkter in NAD+ booster, same scoring method, same rules.